RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy2273
         (434 letters)



>gnl|CDD|189008 cd09601, M1_APN_2, Peptidase M1 Aminopeptidase N family incudes
           tricorn interacting factor F3, Endoplasmic reticulum
           aminopeptidase 1 (ERAP1), Aminopeptidase Q (APQ).  This
           M1 peptidase family includes eukaryotic and bacterial
           members: aminopeptidase N (APN), aminopeptidase Q (APQ,
           laeverin), endoplasmic reticulum aminopeptidase 1
           (ERAP1) as well as tricorn interacting factor F3.
           Aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease,
           consists of a small N-terminal cytoplasmic domain, a
           single transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and is present in a variety
           of human tissues and cell types (leukocyte, fibroblast,
           endothelial and epithelial cells). APN expression is
           dysregulated in inflammatory diseases such as chronic
           pain, rheumatoid arthritis, multiple sclerosis, systemic
           sclerosis, systemic lupus erythematosus,
           polymyositis/dermatomyosytis and pulmonary sarcoidosis,
           and is enhanced in tumor cells such as melanoma, renal,
           prostate, pancreas, colon, gastric and thyroid cancers.
           It is considered a marker of differentiation since it is
           predominantly expressed on stem cells and on cells of
           the granulocytic and monocytic lineages at distinct
           stages of differentiation. Thus, APN inhibition may lead
           to the development of anti-cancer and anti-inflammatory
           drugs. ERAP1 also known as endoplasmic reticulum
           aminopeptidase associated with antigen processing
           (ERAAP), adipocyte derived leucine aminopeptidase
           (A-LAP) or aminopeptidase regulating tumor necrosis
           factor receptor I (THFRI) shedding (ARTS-1), associates
           with the closely related ER aminopeptidase ERAP2, for
           the final trimming of peptides within the ER for
           presentation by MHC class I molecules. ERAP1 is
           associated with ankylosing spondylitis (AS), an
           inflammatory arthritis that predominantly affects the
           spine. ERAP1 also aids in the shedding of membrane-bound
           cytokine receptors. The tricorn interacting factor F3,
           together with factors F1 and F2, degrades the tricorn
           protease products, producing free amino acids, thus
           completing the proteasomal degradation pathway. F3 is
           homologous to F2, but not F1, and shows a strong
           preference for glutamate in the P1' position. APQ, also
           known as laeverin, is specifically expressed in human
           embryo-derived extravillous trophoblasts (EVTs) that
           invade the uterus during early placentation. It cleaves
           the N-terminal amino acid of various peptides such as
           angiotensin III, endokinin C, and kisspeptin-10, all
           expressed in the placenta in large quantities. APN is a
           receptor for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs are also putative Cry toxin
           receptors. Cry1 proteins are pore-forming toxins that
           bind to the midgut epithelial cell membrane of
           susceptible insect larvae, causing extensive damage.
           Several different toxins, including Cry1Aa, Cry1Ab,
           Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to
           bind to APNs; however, a direct role of APN in
           cytotoxicity has been yet to be firmly established.
          Length = 446

 Score =  121 bits (306), Expect = 2e-30
 Identities = 41/102 (40%), Positives = 56/102 (54%), Gaps = 2/102 (1%)

Query: 156 ERYVASTVFEPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLK-TAEDGESRV 214
            RY+A+T FEP  AR  FPCFDEP FKA F++ I  P   ++LSNMP+          + 
Sbjct: 113 TRYLAATQFEPTDARRAFPCFDEPAFKATFTITITHPAGYTALSNMPVESEEVLGDGWKT 172

Query: 215 DHFQESMPMSPYLLCFTVGSFESLTLW-DNSIQYKVYAPRND 255
             F+ + PMS YL+ F VG F+ +     N +  +VYA    
Sbjct: 173 TEFETTPPMSTYLVAFVVGDFDYVEGTTKNGVPVRVYARPGK 214


>gnl|CDD|216501 pfam01433, Peptidase_M1, Peptidase family M1.  Members of this
           family are aminopeptidases. The members differ widely in
           specificity, hydrolysing acidic, basic or neutral
           N-terminal residues. This family includes leukotriene-A4
           hydrolase, this enzyme also has an aminopeptidase
           activity.
          Length = 390

 Score =  101 bits (255), Expect = 9e-24
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 31/217 (14%)

Query: 66  THYQVDLTGGTYQPYLSG------LPDSDLLALVLSTHEVQSQSSVEVGQSFVNPNVVPI 119
            HY + LT    +P  SG         +    +VL + +++  S    G+     N++ +
Sbjct: 9   IHYDLTLTPDFEKPTFSGSVTITLQAKAATNEIVLHSKDLEITSVTLRGEPVSVNNLISV 68

Query: 120 FDGHSGLPDSDLLALDVFEKVAAK-----FFEHCSK---------RLWVSE------RYV 159
           F       + + L +++   + A        E+  K         R    +      + +
Sbjct: 69  FQLD---DEDEFLVINLASTLQAGQPYTLEIEYEGKLNDDMRGFYRSQYLDQTNGEKKPM 125

Query: 160 ASTVFEPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKTAEDGESRV-DHFQ 218
           A+T FEP  AR  FPCFDEP  KA F + I  P   ++LSNMP +++    + RV   F+
Sbjct: 126 ATTQFEPTDARRAFPCFDEPSVKATFDITINHPADYTALSNMPEIESEPLDDGRVITEFE 185

Query: 219 ESMPMSPYLLCFTVGSFESLTLWDNSIQ-YKVYAPRN 254
            +  MS YLL F VG  E L     S    +VYA   
Sbjct: 186 TTPKMSTYLLAFAVGDLEYLETKTKSGVPVRVYARPG 222


>gnl|CDD|223385 COG0308, PepN, Aminopeptidase N [Amino acid transport and
           metabolism].
          Length = 859

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 29/109 (26%), Positives = 40/109 (36%), Gaps = 5/109 (4%)

Query: 158 YVASTVFEPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKTAEDGESRVD-H 216
               T  E   AR +FPC DEP  KA F+L IR       +SN  L+      + R    
Sbjct: 134 PYLITQCEAEGARRIFPCIDEPDVKATFTLTIRADKGPKLISNGNLIDGGTLVDGRKIVK 193

Query: 217 FQESMPMSPYLLCFTVGSFESLTLW----DNSIQYKVYAPRNDSTSWTK 261
           F+++ PM  YL     G  E            +  ++Y P         
Sbjct: 194 FEDTPPMPTYLFALVAGDLEVFRDKFDTRSRDVPLEIYVPPGVLDRAKY 242


>gnl|CDD|189009 cd09602, M1_APN_3, Peptidase M1 family containing Aminopeptidase N.
            This family contains bacterial and eukaryotic
           aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease
           belonging to the M1 gluzincin family. APN consists of a
           small N-terminal cytoplasmic domain, a single
           transmembrane domain and a large extracellular
           ectodomain that contains the active site.  It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and, in higher eukaryotes,
           is present in a variety of human tissues and cell types
           (leukocyte, fibroblast, endothelial and epithelial
           cells). APN expression is dysregulated in inflammatory
           diseases such as chronic pain, rheumatoid arthritis,
           multiple sclerosis, systemic sclerosis, systemic lupus
           erythematosus, polymyositis/dermatomyosytis and
           pulmonary sarcoidosis, and is enhanced in tumor cells
           such as melanoma, renal, prostate, pancreas, colon,
           gastric and thyroid cancers. It is predominantly
           expressed on stem cells and on cells of the granulocytic
           and monocytic lineages at distinct stages of
           differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 438

 Score = 66.5 bits (163), Expect = 6e-12
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 2/105 (1%)

Query: 162 TVFEPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKT-AEDGESRVDHFQES 220
           T FEP+ AR VFPCFD+P  KA F+L +  P   + +SN    +            F E+
Sbjct: 113 TQFEPDDARRVFPCFDQPDLKAPFTLTVTAPKDWTVISNTAATEQSTIRNGYVRWEFPET 172

Query: 221 MPMSPYLLCFTVGSFESLTLWD-NSIQYKVYAPRNDSTSWTKNPD 264
            P+S YL  F  G +  ++  + + I   +Y   + + +  ++ D
Sbjct: 173 PPLSTYLFAFVAGPYHVISDKEHDGIPLGLYCRESLAQALDRDAD 217


>gnl|CDD|189010 cd09603, M1_APN_4, Peptidase M1 family Aminopeptidase N.  This
           family contains mostly bacterial and some archaeal
           aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease
           belonging to the M1 gluzincin family. APN consists of a
           small N-terminal cytoplasmic domain, a single
           transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and, in higher eukaryotes,
           is present in a variety of human tissues and cell types
           (leukocyte, fibroblast, endothelial and epithelial
           cells). APN expression is dysregulated in inflammatory
           diseases such as chronic pain, rheumatoid arthritis,
           multiple sclerosis, systemic sclerosis, systemic lupus
           erythematosus, polymyositis/dermatomyosytis and
           pulmonary sarcoidosis, and is enhanced in tumor cells
           such as melanoma, renal, prostate, pancreas, colon,
           gastric and thyroid cancers. It is predominantly
           expressed on stem cells and on cells of the granulocytic
           and monocytic lineages at distinct stages of
           differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 415

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 26/88 (29%), Positives = 38/88 (43%)

Query: 153 WVSERYVASTVFEPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKTAEDGES 212
           W        T  +P  A   FPC D P  KA F + +  P   + +SN  L+   + G  
Sbjct: 100 WEEGPDGVWTAGQPEGASTWFPCNDHPSDKATFDISVTVPAGYTVVSNGRLVSRTDLGGR 159

Query: 213 RVDHFQESMPMSPYLLCFTVGSFESLTL 240
              H++   PM+ YL+   VG +E L  
Sbjct: 160 TTWHWRMDEPMATYLVTLAVGRYEVLED 187


>gnl|CDD|233857 TIGR02412, pepN_strep_liv, aminopeptidase N, Streptomyces lividans
           type.  This family is a subset of the members of the
           zinc metallopeptidase family M1 (pfam01433), with a
           single member characterized in Streptomyces lividans 66
           and designated aminopeptidase N. The spectrum of
           activity may differ somewhat from the aminopeptidase N
           clade of E. coli and most other Proteobacteria, well
           separated phylogenetically within the M1 family. The M1
           family also includes leukotriene A-4
           hydrolase/aminopeptidase (with a bifunctional active
           site).
          Length = 831

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 29/92 (31%), Positives = 40/92 (43%)

Query: 162 TVFEPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKTAEDGESRVDHFQESM 221
           T FEP  AR VF  FD+P  KA F   ++ P   + +SN        +   R   F E+ 
Sbjct: 122 TQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNSRETDVTPEPADRRWEFPETP 181

Query: 222 PMSPYLLCFTVGSFESLTLWDNSIQYKVYAPR 253
            +S YL     G + S+     S    +YA R
Sbjct: 182 KLSTYLTAVAAGPYHSVQDESRSYPLGIYARR 213


>gnl|CDD|189006 cd09599, M1_LTA4H, Peptidase M1 family contains leukotriene A4
           hydrolase.  This family includes leukotriene A4
           hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog
           cold-active aminopeptidase (Colwellia
           psychrerythraea-type peptidase; ColAP), both members of
           the aminopeptidase M1 family. LTA4H, is a bifunctional
           enzyme possessing an aminopeptidase as well as an
           epoxide hydrolase activity.  The two activities occupy
           different, but overlapping sites. The activity and
           physiological relevance of the aminopeptidase is as yet
           unknown while the epoxide hydrolase converts leukotriene
           A4 (LTA4) into leukotriene B4 (LTB4), a potent
           chemotaxin that is fundamental to the inflammatory
           response of mammals. It accepts a variety of substrates,
           including some opioid, di- and tripeptides, as well as
           chromogenic aminoacyl-p-nitroanilide derivatives. The
           aminopeptidase activity of LTA4H is possibly involved in
           the processing of peptides related to inflammation and
           host defense. Kinetic analysis shows that LTA4H
           hydrolyzes arginyl tripeptides with high efficiency and
           specificity, indicating its function as an arginyl
           aminopeptidase. LTA4H is overexpressed in certain human
           cancers, and has been identified as a functionally
           important target for mediating anticancer properties of
           resveratrol, a well known red wine polyphenolic compound
           with cancer chemopreventive activity.
          Length = 442

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 25/75 (33%), Positives = 41/75 (54%), Gaps = 4/75 (5%)

Query: 165 EPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKTAEDGES--RVDHFQESMP 222
           +   AR++FPC D P  K+ +S  +  P  +++L  M  +   EDGE   +  HF++ +P
Sbjct: 132 QAIHARSLFPCQDTPSVKSTYSATVTVPKELTAL--MSAIPPVEDGEEPRKTYHFEQPVP 189

Query: 223 MSPYLLCFTVGSFES 237
           +  YL+   VG  ES
Sbjct: 190 IPSYLIAIAVGDLES 204


>gnl|CDD|189002 cd09595, M1, Peptidase M1 family contains aminopeptidase N and
           leukotriene A4 hydrolase.  M1 Peptidase family includes
           aminopeptidase N (APN) and leukotriene A4 hydrolase
           (LTA4H).  All peptidases in this family bind a single
           catalytic zinc ion which is tetrahedrally co-ordinated
           by three amino acid ligands and a water molecule that
           forms the nucleophile on activation during catalysis.
           APN consists of a small N-terminal cytoplasmic domain, a
           single transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and is present in a variety
           of human tissues and cell types. APN expression is
           dysregulated in many inflammatory diseases and is
           enhanced in numerous tumor cells, making it a lead
           target in the development of anti-cancer and
           anti-inflammatory drugs. LTA4H is a bifunctional enzyme,
           possessing an aminopeptidase as well as an epoxide
           hydrolase activity. The two activities occupy different,
           but overlapping sites. The activity and physiological
           relevance of the aminopeptidase in LTA4H is as yet
           unknown while the epoxide hydrolase converts leukotriene
           A4 (LTA4) into leukotriene B4 (LTB4), a potent
           chemotaxin that is fundamental to the inflammatory
           response of mammals.
          Length = 407

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 8/85 (9%)

Query: 157 RYVASTVFEPNLARNVFPCFDEPHFKA-YFSLMIRRPHHMSSLSNMPLLKTAEDGESR-- 213
            ++ S   E   AR+ FPC D P   A Y++ +      + + SN       +DGE R  
Sbjct: 105 AFLFSQ-GEAIGARSWFPCQDRPDSVATYYTTVTVPDKTLVAASNGN----KDDGEVRRK 159

Query: 214 VDHFQESMPMSPYLLCFTVGSFESL 238
              F   +P++PYL+   VG  E  
Sbjct: 160 WVEFSPPIPIAPYLIALVVGDLEYP 184


>gnl|CDD|233856 TIGR02411, leuko_A4_hydro, leukotriene A-4
           hydrolase/aminopeptidase.  Members of this family
           represent a distinctive subset within the zinc
           metallopeptidase family M1 (pfam01433). The majority of
           the members of pfam01433 are aminopeptidases, but the
           sequences in this family for which the function is known
           are leukotriene A-4 hydrolase. A dual epoxide hydrolase
           and aminopeptidase activity at the same active site is
           indicated. The physiological substrate for
           aminopeptidase activity is not known.
          Length = 602

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 20/79 (25%), Positives = 36/79 (45%), Gaps = 3/79 (3%)

Query: 169 ARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKTAEDGESRVDHFQESMPMSPYLL 228
           AR++FPC D P  K+ ++  +  P     +S +   +T+ D       F++ +P+  YL+
Sbjct: 135 ARSLFPCQDTPSVKSTYTAEVESP-LPVLMSGIRDGETSND--PGKYLFKQKVPIPAYLI 191

Query: 229 CFTVGSFESLTLWDNSIQY 247
               G   S  +   S  Y
Sbjct: 192 AIASGDLASAPIGPRSTVY 210


>gnl|CDD|189018 cd09839, M1_TAF2, TATA binding protein (TBP) associated factor 2.
           This family includes TATA binding protein (TBP)
           associated factor 2 (TAF2, TBP-associated factor
           TAFII150, transcription initiation factor TFIID subunit
           2, RNA polymerase II TBP-associated factor subunit B),
           and has homology to the aminopeptidase N (APN)
           subfamily, belonging to the M1 gluzincin family. TAF2 is
           part of the TFIID multidomain subunit complex essential
           for transcription of most protein-encoded genes by RNA
           polymerase II. TAF2 is known to interact with the
           initiator element (Inr) found at the transcription start
           site of many genes, thus possibly playing a key role in
           promoter binding as well as start-site selection. Image
           analysis has shown TAF2 to form a complex with TAF1 and
           TBP, inferring its role in promoter recognition.
           Peptidases in the M1 family bind a single catalytic zinc
           ion which is tetrahedrally co-ordinated by three amino
           acid ligands and a water molecule that forms the
           nucleophile on activation during catalysis. TAF2,
           however, does not seem to contain any of the active site
           residues.
          Length = 507

 Score = 36.6 bits (85), Expect = 0.024
 Identities = 21/75 (28%), Positives = 34/75 (45%), Gaps = 3/75 (4%)

Query: 165 EPNLARNVFPCFDEPHFKAYFSLMIRRPHHMSSLSNMPLLKT---AEDGESRVDHFQESM 221
               AR  FPC D+P     + L    P +M ++S+  LL+     ED   +  H+  ++
Sbjct: 153 IHGSARCWFPCVDDPSQLCTWELEFTVPANMVAVSSGDLLEQVYDTEDMRKKTYHYALTV 212

Query: 222 PMSPYLLCFTVGSFE 236
           P +   +   VG FE
Sbjct: 213 PTAAQNIGLAVGPFE 227


>gnl|CDD|236304 PRK08581, PRK08581, N-acetylmuramoyl-L-alanine amidase; Validated.
          Length = 619

 Score = 34.8 bits (80), Expect = 0.096
 Identities = 29/156 (18%), Positives = 60/156 (38%), Gaps = 6/156 (3%)

Query: 254 NDSTSWTKNPDGSTWENARNSTSSWTKNLDRTTWDNIEKGPQN-YSSSWTNKPAGSWENA 312
           +D TS   +   +   +  N+++    +   +T D+      N     + N P  +    
Sbjct: 48  DDETSKDTSSKDTDKADNNNTSNQDNNDKKFSTIDSSTSDSNNIIDFIYKNLPQTNINQL 107

Query: 313 IQKSSQNDSSSWTKNPNSIF---SDKSQYALVKNLMSVPGSNKPAGSWENAIQKSSQNDS 369
           + K+  +D+ S T    ++F   SD S Y   +N  S   +N    + +++I+  +   S
Sbjct: 108 LTKNKYDDNYSLTTLIQNLFNLNSDISDYEQPRN--SEKSTNDSNKNSDSSIKNDTDTQS 165

Query: 370 SSWTKNPNSTFSDKSQYALGHNIAEGSWPIPVPSNK 405
           S   K  N      +      +  + + P P   N+
Sbjct: 166 SKQDKADNQKAPSSNNTKPSTSNKQPNSPKPTQPNQ 201


>gnl|CDD|199843 cd03859, M14_CPT, Peptidase M14 Carboxypeptidase T subfamily.
           Peptidase M14-like domain of carboxypeptidase (CP) T
           (CPT), CPT belongs to the M14 family of
           metallocarboxypeptidases (MCPs). The M14 family are
           zinc-binding CPs which hydrolyze single, C-terminal
           amino acids from polypeptide chains, and have a
           recognition site for the free C-terminal carboxyl group,
           which is a key determinant of specificity. CPT has
           moderate similarity to CPA and CPB, and exhibits
           dual-substrate specificity by cleaving C-terminal
           hydrophobic amino acid residues like CPA and C-terminal
           positively charged residues like CPB. CPA and CPB are
           M14 family peptidases but do not belong to this CPT
           group. The substrate specificity difference between CPT
           and CPA and CPB is ascribed to a few amino acid
           substitutions at the substrate-binding pocket while the
           spatial organization of the binding site remains the
           same as in all Zn-CPs. CPT has increased thermal
           stability in presence of Ca2+ ions, and two disulfide
           bridges which give an additional stabilization factor.
          Length = 297

 Score = 32.7 bits (75), Expect = 0.32
 Identities = 16/51 (31%), Positives = 20/51 (39%), Gaps = 4/51 (7%)

Query: 262 NPDGSTWENARNSTSSWTKNLDRTTWDNIEKG----PQNYSSSWTNKPAGS 308
           NPDG  ++ A  S  SW KN    + D          +NY   W     GS
Sbjct: 107 NPDGYEYDEATGSYRSWRKNRRPNSGDISSSDGVDLNRNYGYKWGCDSGGS 157


>gnl|CDD|215104 PLN00207, PLN00207, polyribonucleotide nucleotidyltransferase;
           Provisional.
          Length = 891

 Score = 31.0 bits (70), Expect = 1.6
 Identities = 26/110 (23%), Positives = 39/110 (35%), Gaps = 19/110 (17%)

Query: 321 SSSWTKNPNSIF-------------SDKSQYALVKNLMSVPGSNKPAGSWENAIQKSSQN 367
           SS+W   P   F             +DK Q  L +  + +P +N    S +     +   
Sbjct: 788 SSNWLAKPEDAFKVGDRIDVKLIEVNDKGQLRLSRRAL-LPEANSEKSSQKQQGGSTK-- 844

Query: 368 DSSSWTKNPNSTFSDKSQYALGHNIAEGSWPIPVPSNKAVKRLPSEKFDE 417
           D +   K  N++   +       N AE +    VP  K  KR  S   DE
Sbjct: 845 DKAPQKKYVNTSSRPRRAAQAEKNSAENA---AVPKKKDYKRATSGSKDE 891


>gnl|CDD|185721 cd08980, GH43_1, Glycosyl hydrolase family 43.  This glycosyl
           hydrolase family 43 (GH43) includes enzymes with
           beta-xylosidase (EC 3.2.1.37) and
           alpha-L-arabinofuranosidase (EC 3.2.1.55) and possibly
           bifunctional xylosidase/arabinofuranosidase activities.
           These are inverting enzymes (i.e. they invert the
           stereochemistry of the anomeric carbon atom of the
           substrate) that have an aspartate as the catalytic
           general base, a glutamate as the catalytic general acid
           and another aspartate that is responsible for pKa
           modulation and orienting the catalytic acid. Many of the
           enzymes in this family display both
           alpha-L-arabinofuranosidase and beta-D-xylosidase
           activity using aryl-glycosides as substrates. A common
           structural feature of GH43 enzymes is a 5-bladed
           beta-propeller domain that contains the catalytic acid
           and catalytic base. A long V-shaped groove, partially
           enclosed at one end, forms a single extended
           substrate-binding surface across the face of the
           propeller.
          Length = 288

 Score = 30.3 bits (69), Expect = 2.0
 Identities = 30/128 (23%), Positives = 43/128 (33%), Gaps = 40/128 (31%)

Query: 287 WDNIEKGPQN-Y----SSSWT--------NKPAGSWENAIQKSSQNDSSSWTKNPNSIF- 332
           W+    G QN Y    S+ WT        ++P   WE   Q    N+  +  K    +F 
Sbjct: 132 WEGRTNGNQNLYIAKMSNPWTLTGPRVLISRPEYDWER--QGPGVNEGPAALKRNGKVFL 189

Query: 333 ------SDKSQYALVKNLMSVPGSNKPAGSWENAIQKSSQNDSSSWTKNPN---STFSDK 383
                 S    Y L   L++  G                  D +SWTK+P     +  + 
Sbjct: 190 TYSASGSWTPDYCL--GLLTADGGADLL-------------DPASWTKSPTPVFQSSPEN 234

Query: 384 SQYALGHN 391
             Y  GHN
Sbjct: 235 GVYGPGHN 242


>gnl|CDD|222007 pfam13249, Prenyltrans_2, Prenyltransferase-like. 
          Length = 112

 Score = 28.5 bits (64), Expect = 3.0
 Identities = 14/60 (23%), Positives = 21/60 (35%), Gaps = 2/60 (3%)

Query: 315 KSSQNDSSSWTKNPNSIFSDKSQYALVKNLMSVPGSNKPAGSWENAIQ--KSSQNDSSSW 372
            S QN    +  +P S   D S  A     + + G      + E A+    S QN    +
Sbjct: 51  LSQQNPDGGFGYDPQSNSPDLSSTAYALAALELLGGEPDDEAVEKAVDYLLSCQNPDGGF 110


>gnl|CDD|227493 COG5164, SPT5, Transcription elongation factor [Transcription].
          Length = 607

 Score = 30.0 bits (67), Expect = 3.1
 Identities = 22/156 (14%), Positives = 39/156 (25%), Gaps = 32/156 (20%)

Query: 259 WTKNPDGSTWE----NARNSTSSWTKNLDRTTWDNIEKGPQ----NYSSSWTNKPAGSWE 310
           W   P          +  +   +W K                    + ++W  +   + E
Sbjct: 460 WKDGPKTPALNDPGIDWGDEKDNWYKGSLIHALGKGLALEDYRDGLFMTAWKGQATSASE 519

Query: 311 NAIQKSSQNDSSSWTKNPNSIFSDKSQYALVKNLMSVPG-SNKPAGSWENAIQKSSQNDS 369
            +  +   N+                   L        G  N   G W   + +S++   
Sbjct: 520 ISFVQPRWNNLVCV---------------LDGEKKGTCGILNGINGDWGGTVIRSTKGSV 564

Query: 370 SSWTKNPNSTFSDKSQYALGHNIAEGSWPIPVPSNK 405
             W  N NS    K  Y  G      +W      N+
Sbjct: 565 VHWPMNDNS----KKIYDGG----ASAWGNQDDGNR 592


>gnl|CDD|235060 PRK02710, PRK02710, plastocyanin; Provisional.
          Length = 119

 Score = 28.1 bits (63), Expect = 3.6
 Identities = 15/50 (30%), Positives = 25/50 (50%), Gaps = 7/50 (14%)

Query: 86  DSDLLALVLSTHEVQSQSSVEVGQSFVNPNVVP---IFDGHSGLPDSDLL 132
           D+ +LA   ST  +++  +V+    +VN  + P   +FDG   L   DL 
Sbjct: 38  DAGMLAFEPSTLTIKAGDTVK----WVNNKLAPHNAVFDGAKELSHKDLA 83


>gnl|CDD|215595 PLN03130, PLN03130, ABC transporter C family member; Provisional.
          Length = 1622

 Score = 28.6 bits (64), Expect = 8.1
 Identities = 10/19 (52%), Positives = 12/19 (63%)

Query: 241 WDNSIQYKVYAPRNDSTSW 259
           W+NS Q KV   R+D  SW
Sbjct: 497 WENSFQSKVQTVRDDELSW 515


>gnl|CDD|211988 TIGR04265, bac_cardiolipin, cardiolipin synthase.  This model is
           based on experimentally characterized bacterial
           cardiolipin synthases (cls) from E. coli, Staphylococcus
           aureus (two), and Bacillus pseudofirmus OF4. This model
           describes just one of several homologous but
           non-orthologous forms of cls. The cutoff score is set
           arbitrarily high to avoid false-positives. Note that
           there are two enzymatic activites called cardiolipin
           synthase. This model represents type 1, which does not
           rely on a CDP-linked donor, but instead does a
           reversible transfer of a phosphatidyl group from one
           phosphatidylglycerol molecule to another.
          Length = 483

 Score = 28.6 bits (64), Expect = 8.4
 Identities = 14/51 (27%), Positives = 23/51 (45%), Gaps = 1/51 (1%)

Query: 279 TKNLD-RTTWDNIEKGPQNYSSSWTNKPAGSWENAIQKSSQNDSSSWTKNP 328
           T N+D R+ W N E     Y   +    A ++++ I +S Q     + K P
Sbjct: 416 TANMDMRSFWLNFEVNAFIYDKGFAKDLAAAYDDDISRSRQLTKRLYAKRP 466


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.312    0.126    0.385 

Gapped
Lambda     K      H
   0.267   0.0686    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 20,945,731
Number of extensions: 1881828
Number of successful extensions: 1025
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1017
Number of HSP's successfully gapped: 35
Length of query: 434
Length of database: 10,937,602
Length adjustment: 100
Effective length of query: 334
Effective length of database: 6,502,202
Effective search space: 2171735468
Effective search space used: 2171735468
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.2 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 42 (21.9 bits)
S2: 60 (27.0 bits)